GEN Exclusives

More »

GEN News Highlights

More »
Apr 23, 2013

Layoffs and Breakup at Roche

  • Roche today announced the dissolution of its Applied Science Business Area, which is part of the firm’s Diagnostics Division. This restructuring move will affect approximately 110 positions in Penzberg, Germany, and another 60 in Branford, CT, the company said.

    The firm’s Applied Science portfolio will be integrated within its other diagnostics business areas. In a statement, Roche said the changes are meant to “streamline decision-making and enhance technology flow from research use to the clinical setting.”

    Additionally, Roche has ended of its quest to develop a nanopore-based sequencing platform in partnership with IBM. The company cites technical risks.

    “Following assessment of its sequencing R&D portfolio, Roche has decided to return the ISFET project for the development of a semiconductor-based sequencing system to DNA Electronics,” the company said. “Roche believes that it will be unable to disrupt the market with the product at launch.”

    In a statement, Roche added that it “remains committed to the life-science business.”


Add a comment

  • You must be signed in to perform this action.
    Click here to Login or Register for free.
    You will be taken back to your selected item after Login/Registration.

Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Block That Microbiome Metaphor!

Which way of thinking about the microbiome would best integrate the virome’s contributions?